Speaker

Dr. Binghe Xu is the academician of Chinese Academy of Engineering, Director of Clinical Trial Center, and Former Director, Department of Medical Oncology at the National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences CAMS and Peking Union Medical College (PUMC）in Beijing, China.

Dr. Xu is the leading PI of several regional and global multicenter clinical trials and an executive steering committee (EC) as well as steering committee (SC) member of several global clinical trials for breast cancer. He has made great contributions to the innovative research and development of anticancer drugs in China.

Dr. Xu has published 490 papers in peer-reviewed oncology journals. Of these papers, 420 were published with Dr. Xu serving as a corresponding author in journals such as British Medical Journal, Nature Medicine, Cancer Cell, The Lancet Oncology, Annals of Oncology, Journal of Clinical Oncology. He was awarded the second prize of National Science and Technology Progress Award, Ho Leung Ho Lee Foundation Science and Technology Progress Award, and National Innovation Pioneer Award et al.

Dr. Xu is a panel member of the St. Gallen International Consensus on the Primary Therapy of Early Breast Cancer， ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer and the Clinical Practice Guideline on eBC.